Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Cancer Gene Therapy|February 6, 2025
Methylstat sensitizes ovarian cancer cells to PARP-inhibition by targeting the histone demethylases JMJD1B/CFranziska Maria Schwarz, Daniel Martin Klotz, Ruming Yang, et al.
Clinical Chemistry|July 13, 2014
ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistanceJan Dominik Kuhlmann, Pauline Wimberger, Agnes Bankfalvi, et al.
NPJ Precision Oncology|January 24, 2026
Exploring translational relevance of baseline and longitudinal metabolic profiling in the blood of ovarian cancer patientsAlexander Max Funk, Lisa Freitag, Franziska Maria Schwarz, et al.
Clinical Chemistry and Laboratory Medicine|October 23, 2021
Evaluation of circulating Dickkopf-1 as a prognostic biomarker in ovarian cancer patientsDaniel Martin Klotz, Theresa Link, Maren Goeckenjan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2026
A urinary three-metabolite signature enables non-invasive identification of high-risk ovarian cancer patientsAlexander Max Funk, Mareike Brieske, Franziska Maria Schwarz, et al.
Oncotarget|September 15, 2017
Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpressionTheresa Link, Friederike Kuithan, Armin Ehninger, et al.
Cancers|February 15, 2022
Decoding Single Cell Morphology in Osteotropic Breast Cancer Cells for Dissecting Their Migratory, Molecular and Biophysical HeterogeneityLila Bemmerlein, Ilker A Deniz, Jana Karbanová, et al.
Cancers|November 13, 2021
ADAM17-A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian CancerChristoph Rogmans, Jan Dominik Kuhlmann, Gerrit Hugendieck, et al.
Molecular Cancer|August 23, 2024
Induction of circulating ABCB1 transcripts under platinum-based chemotherapy indicates poor prognosis and a bone micrometastatic phenotype in ovarian cancer patientsFranziska Maria Schwarz, Jan Dominik Kuhlmann, Jorrin Kämpfer, et al.
Cancers|August 12, 2023
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian CancerDaniel Martin Klotz, Franziska Maria Schwarz, Anna Dubrovska, et al.
Pageof 6